Columbus Public Health’s data library links HealthMap 2025, a collaborative assessment involving the Central Ohio Hospital Council, Columbus Public Health, and Franklin County Public Health. It also distinguishes city, county, and state measures in its community indicators. Those boundaries matter when building a business case. A Franklin County finding should not automatically be described as a Columbus city fact or an individual patient characteristic.
Use the public evidence to choose research questions about access and continuity. A founder might study what happens between a requested appointment and completion of a necessary test, or how patients obtain records from an existing doctor. Interview prospective users about timing, privacy, language support, and the costs of the whole plan. Avoid assuming that a statewide clinical rule or a regional health assessment establishes a ready market. The first pilot should test a specific improvement in the patient journey and make its unverified assumptions visible.
An effective Columbus planning document can map each requirement in the Ohio encounter rule to a specific record and responsible role. For example, identify where the patient’s location is captured, how a correction reaches the clinician, and where the consent process is documented. Then test the resulting workflow rather than merely checking that the application has fields with the right names. A field that is never reviewed or becomes stale after scheduling does not provide the same operational evidence as a confirmed encounter record.
For market research, ask prospective users to walk through a complete hypothetical care plan. Include a result that needs interpretation and a question after the appointment. The exercise can reveal whether the person expects support from the platform, the treating group, a pharmacy, or an existing doctor. Resolve confusing boundaries before launch. Columbus’s public-health resources can help frame local access questions, while these interviews test whether the proposed service is understandable. Keep those two evidence types distinct and avoid presenting usability findings as proof of clinical effectiveness.